Highlights
- 1Communications biology · 2023
- 2Cell reports · 2020
- 3Science advances · 2022
Publications
46 publications
Funding
2 grantsView NIH portfolio on RePORTER ↗
Active
1 grant- PIR01HD112441-04Anti-Mullerian hormone for preserving ovarian function before administration of gonadotoxic therapies or after transplantation of cryopreserved tissue.Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2023–2028
Completed grants (1)
- PIR21HD103956-02Optimized protocols for ovarian tissue cryopreservation and novel modRNA-based approaches to improve transplantation outcomes for fertility preservation in chronically diseased girlsEunice Kennedy Shriver National Institute of Child Health and Human Development · 2021–2024
Clinical research
3 studies
Active
3 studies- PINanosensor Observations for Timely Identification of Complications after Embryo TransferWeill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2026)
- PIQUANTUM DEFECT-MODIFIED CARBON NANOTUBE ARRAYS in IVFWeill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2025)
- PIDifferences in RNA profiles in Granulosa cells from mature versus immature oocytesWeill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2020)
News mentions
1 mentionView all WCM news ↗
- Anti-Müllerian Hormone May Contribute to Infertility in Polycystic Ovary SyndromeMarch 9, 2022
High levels of anti-Mullerian hormone (AMH) have traditionally been thought of as merely a passive byproduct of polycystic ovary syndrome (PCOS), but a new preclinical study by Weill Cornell Medicine researchers suggests that the hormone plays an active role in the disorder and may contribute to problems with ovulation and fertility.
Mentoring
1 mentee